High dose vitamin C found to be a safe and effective addition to cancer treatment

Print Friendly, PDF & Email

iv-vitamin-c-bag(NaturalHealth365) It’s official: Vitamin C can not only be safely combined with conventional cancer treatment, but it can lead to better survival outcomes, and a longer life, for people suffering from glioblastoma – a highly aggressive form of brain cancer.

In research published just last month, researchers used doses of vitamin C that were from 800 to 1,000 times higher than the recommended daily amount – all without major adverse effects. The only question, now, is when will Western medicine fully embrace the use of vitamin C for cancer patients?

Nine-month study explored effects of high-dose vitamin C on brain cancer

In a Phase I safety trial published last month in Cancer Cell, researchers at the University of Iowa gave brain cancer patients three infusions of vitamin C a week for two months, then two infusions a week for seven months. Patients also received standard cancer care, including radiation and chemotherapy.

With a half-life of only two hours in humans, vitamin C must be used in large amounts to achieve the high blood concentrations necessary for therapeutic effects. In this study, the researchers wanted to raise the participants’ blood concentrations of vitamin C to a sky-high 2,000 micromoles – in contrast to the 70 micromoles normally found in adults.

Natural health experts have long insisted that vitamin C must be administered in high doses in order to be successful, and attribute the sometimes-disappointing results of anti-cancer vitamin C studies to insufficient doses.

The key question: What did the study show?

The results of the Phase I safety trial were extremely encouraging. Patients experienced an increase in overall survival time of 4 to 6 months – thereby allowing them to survive for a total of 18 to 22 months – almost two years – as opposed to the typical 14 to 16 months.

Did you know?  The liver is the most important detoxifying organ in the body.  When the liver can’t effectively neutralize and dispose of toxins, they accumulate in the body.  Two essential nutrients for healthy liver function are milk thistle and glutathione.  These two ingredients - plus much more – are now available in an advanced liver support formula.  Click here to learn more.

Researchers noted that the vitamin C was well tolerated, and featured only minor side effects such as dry mouth – along with rare, fleeting episodes of elevated blood pressure.

Calling the results “promising,” the study authors said they were “guardedly optimistic” about vitamin C’s cancer-fighting potential — pending the results of the Phase II trials. (of course, one can only wonder how these patients would have done with additional non-toxic cancer therapies)

Vitamin C works against cancer by selectively targeting the “Achilles heel” of cancer cells

According to researchers, a specific pathway of altered iron metabolism in cancer cells gives them a fatal weakness that allows vitamin C to sensitize them to radiation and chemotherapy – triggering their death, while making remaining cells more susceptible to standard cancer treatment.

The key to vitamin C’s powers is the fact that it is a “redox active” compound, making it effective on tumor tissues – which have unusually high levels of redox active iron molecules caused by abnormal mitochondrial metabolism.

These molecules react with vitamin C to form hydrogen peroxide and accompanying free radicals, which then cause damage to the DNA of cancer cells – all without harming normal, healthy cells.

Earlier studies support vitamin C’s cancer-fighting effects

Although this is the most recent study on vitamin C’s cancer-fighting powers, it is by no means the only one. Past research has shown that a combination of intravenous high-dose vitamin C and chemotherapy drugs helped to slow the progression of cancer, while alleviating side effects of chemotherapy drugs.

In a 2015 study conducted at Weill Cornell Medicine in New York, researchers found that high-dose vitamin C caused oxidative damage in cancer cells, resulting in impaired tumor growth in colorectal tumors.

And, it used an interesting mechanism to do so.

Normally, a small amount of vitamin C always becomes oxidized into dehydroascorbic acid, or DHA, which acts as a “Trojan horse” in cancer cells. As DHA, it can freely enter cancer cells – something that doesn’t happen with ascorbic acid.

The cancer cells automatically try to convert the DHA back to ascorbic acid – but deplete their antioxidants and die in the process.

Because glucose transport protein helps with the entry of DHA into cells, researchers believe that high-dose vitamin C may work particularly well on cancer cells – such as the KRAS- and BRAF- mutant cells of colorectal cancer, that have high levels of this protein.

Phase II clinical trials are the next step for high-dose vitamin C

Research into vitamin C’s anticancer effects is ongoing, with researchers currently enrolling patients with Stage 4 lung cancer and glioblastoma in Phase II clinical trials. In Phase II studies, patients receive the highest dose of the treatment that did not cause harmful effects in the Phase 1 section.

As with the Phase I trial, researchers are eager find out more about vitamin C’s ability to extend lifespan and improve quality of life for patients undergoing radiation and chemotherapy.

Incidentally, the entire nine-month protocol of vitamin C treatment carried an $8,000 price tag above standard insurance billing – less than the cost of a single dose of some immunotherapy and chemotherapy drugs.

Safe, non-toxic , low-cost and effective, vitamin C seems poised to take its place as a promising cancer treatment of the twenty-first century.

Sources for this article include:

EurekAlert.org
ScienceDaily.com
Cell.com
MedicalNewsToday.com
MedicalNewsToday.com